T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Kai Rejeski(Memorial Sloan Kettering Cancer Center), Roni Shouval(Memorial Sloan Kettering Cancer Center), Tsila Zuckerman(Johannes Gutenberg University Mainz), Marina Gómez-Llobell(Universidad Complutense de Madrid), Avichai Shimoni, Ronit Marcus(Sheba Medical Center), Frederick L. Locke(Moffitt Cancer Center), Gunjan L. Shah(Cornell University), Monica Nair(National Institutes of Health), Marcela V. Maus(Center for Cancer Research), Nirali N. Shah(National Institutes of Health), Ofrat Beyar‐Katz(Rambam Health Care Campus), Jaime Sanz(Hospital Universitari i Politècnic La Fe), Veit Bücklein(LMU Klinikum), Netta Glaubach(Rambam Health Care Campus), Michael Scordo(Cornell University), M. Lia Palomba(Memorial Sloan Kettering Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Abraham Avigdor(Sheba Medical Center), Jonathan H. Esensten(Memorial Sloan Kettering Cancer Center), Sandeep Raj(Memorial Sloan Kettering Cancer Center), Sham Mailankody(Memorial Sloan Kettering Cancer Center), Sridevi Rajeeve(Memorial Sloan Kettering Cancer Center), Orit Itzhaki(Sheba Medical Center), Sigrun Einarsdottir(Memorial Sloan Kettering Cancer Center), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Gilles Salles(Memorial Sloan Kettering Cancer Center), Marcelo C. Pasquini(Cleveland Clinic), Yannis K. Valtis(Brigham and Women's Hospital), Tobias Tix(LMU Klinikum), Teng Fei(Wuhan University), Jae H. Park(Memorial Sloan Kettering Cancer Center), Noa Golan-Accav(Tel Aviv University), Iris Halamis(Rambam Health Care Campus), Hamza Hashmi(Medical University of South Carolina), Ori Ben Valid(Tel Aviv University), Saad Z. Usmani(Memorial Sloan Kettering Cancer Center)
Blood
April 21, 2025
Cited by 31


Related Papers